The nation of Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) spanning five years over Washington's request for confidential biological samples.
This rejection was revealed after a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government spokesman has since explained that the US was seeking genetic material for research and commercial purposes while refused to share the benefits from any future treatments.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for further negotiations to find a deal suitable to all parties so the nation's vital HIV treatment initiative can continue.
Broader Background
This development comes after a similar situation in neighbouring Kenya, where a court blocked a similar health funding agreement following concerns were filed about the security of citizens' medical information.
Since resuming office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had administered assistance for the US government, but Trump argued its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.
As per reports, 16 African countries have to date agreed to these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, without any corresponding guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our country would supply the basic resources for medical research without any assurance that the end products would be accessible to our population if a new pandemic arise."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were upending frameworks previously established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to manage potential global health emergencies.
"This system is designed to guarantee that when a country provides its information, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to develop them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our US partners on how future co-operation could be structured in a manner that honours the independence and dignity of both nations."
Health Experts Response
Medical experts stated it acknowledged the government's concerns, but urged that talks need to persist considering much of the nation's HIV programmes relied on foreign aid.
"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group added.
The halted deal highlights the complex tensions between receiving crucial international aid and protecting local interests in an increasingly interconnected world.